Edition:
United States

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

7.11USD
15 Dec 2017
Change (% chg)

$-0.09 (-1.25%)
Prev Close
$7.20
Open
$7.11
Day's High
$7.33
Day's Low
$7.11
Volume
3,659
Avg. Vol
3,043
52-wk High
$7.95
52-wk Low
$5.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 8.67 -0.322
Mar '17 9.64 -0.079
FY 2016 Dec '16 9.08 -0.046
Sep '16 8.79 0.006
Jun '16 7.41 -0.003
Mar '16 7.74 -0.015
FY 2015 Dec '15 8.04 0.009
Sep '15 7.89 0.007
Jun '15 8.91 0.024
Mar '15 8.69 0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. 122.95 40.75 45.35
P/E Low - Last 5 Yrs. 14.22 23.60 24.23
Beta 0.86 0.92 0.91
Price to Sales (TTM) 2.90 3.92 5.95
Price to Book (MRQ) 1.72 4.85 5.68
Price to Tangible Book (MRQ) 2.57 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 35.05 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 27.36 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago 20.64 5.15 5.62
Sales - 5 Yr. Growth Rate -8.38 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -828.30 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago -16,237.29 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate 37.24 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.81 2.49 2.55
Current Ratio (MRQ) 4.18 3.50 3.56
LT Debt to Equity (MRQ) 12.29 11.01 13.38
Total Debt to Equity (MRQ) 12.29 17.15 19.38
Interest Coverage (TTM) -- 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 82.32 55.26 54.91
Gross Margin - 5 Yr. Avg. 85.64 52.35 52.46
EBITD Margin (TTM) -4.02 -- --
EBITD - 5 Yr. Avg 9.27 18.50 15.63
Operating Margin (TTM) -10.72 14.76 6.56
Operating Margin - 5 Yr. Avg. 4.48 14.33 11.00
Pre-Tax Margin (TTM) -10.30 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. 4.90 14.64 11.41
Net Profit Margin (TTM) -20.73 11.39 3.64
Net Profit Margin - 5 Yr. Avg. 3.08 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. 37.06 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 470,516 945,342,213 851,801,741
Net Income/Employee (TTM) -97,536 110,573,246 99,542,701
Receivable Turnover (TTM) 5.56 5.90 6.13
Inventory Turnover (TTM) 1.26 2.73 3.56
Asset Turnover (TTM) 0.43 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -8.82 11.86 11.31
Return on Assets - 5 Yr. Avg. 1.21 12.86 12.28
Return on Investment (TTM) -10.37 15.06 14.43
Return on Investment - 5 Yr. Avg. 1.37 16.81 16.07
Return on Equity (TTM) -11.36 16.55 16.01
Return on Equity - 5 Yr. Avg. 1.48 17.82 17.27
  1 Year 3 Year 5 Year
Sales % -1.47 1.03 -8.38
EPS (TTM) % -236.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cumberland Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.49 -11.81 14 49
13 Week 3.80 -3.02 56 16
26 Week 2.16 -7.11 51 31
52 Week 29.98 9.88 75 25
YTD 29.27 8.16 73 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 35.04%
# of Holders: 45
Total Shares Held: 5,518,878
3 Mo. Net Change: -33,627
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 10
# Reduced Positions: 20
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.